Coxsackievirus B3 (CVB3), a common human pathogen for viral myocarditis, induces a direct cytopathic effect (CPE) and apoptosis on infected cells. To elucidate the mechanisms that contribute to these processes, we studied the role of glycogen synthase kinase 3b (GSK3b). GSK3b activity was significantly increased after CVB3 infection and addition of tyrosine kinase inhibitors blocked CVB3-triggered GSK3b activation. Inhibition of caspase activity had no inhibitory effect on CVB3-induced CPE; however, blockage of GSK3b activation attenuated both CVB3-induced CPE and apoptosis. We further showed that CVB3 infection resulted in reduced b-catenin protein expression, and GSK3b inhibition led to the accumulation and nuclear translocation of b-catenin. Finally, we found that CVB3-induced CPE and apoptosis were significantly reduced in cells stably overexpressing b-catenin. Taken together, our results demonstrate that CVB3 infection stimulates GSK3b activity via a tyrosine kinasedependent mechanism, which contributes to CVB3-induced CPE and apoptosis through dysregulation of b-catenin.
Introduction
Coxsackievirus B3 (CVB3), a member of genus Enterovirus within the family of Picornaviridae, is the primary causative agent of viral myocarditis. 1, 2 In North America, viral myocarditis accounts for approximately 20% of sudden, unexpected death and heart failure in children and adolescents. 3 In those patients that survive, human studies strongly suggest that the major chronic sequela is dilated cardiomyopathy, which is responsible for approximately 50% of the more than 57 000 cardiac transplants now registered worldwide. 4 Apoptosis plays an important role in the pathogenesis of a number of diseases, and has been shown to be associated with myocarditis and chronic dilated cardiomyopathy. 5, 6 Cumulative evidence suggests that both early direct virusmediated injury and subsequent inflammatory responses contribute to the injury of cardiac myocytes and the extent of such injury determines the severity of late stage organ dysfunction. 2, 7, 8 In experimental animal models, CVB3 infection results in extensive apoptotic and necrotic phenotypic alterations of cardiomyocytes. 9 In cultured cells, CVB3 infection is capable of inducing a direct cytopathic effect (CPE, a degenarative change in morphology) and cell apoptosis. 10, 11 We have recently demonstrated that the mitochondria-mediated apoptotic pathway that is involved in the early cell death and apoptosis during the late phase of virus infection facilitates viral progeny release. 10, 11 However, thus far, the precise mechanisms underlying development of the CPE and apoptosis remain to be elucidated.
Glycogen synthase kinase 3b (GSK3b), a serine/threonine protein kinase, was initially identified as an enzyme that inhibits glycogen synthesis through phosphorylation of glycogen synthase. Recent studies have revealed that GSK3b regulates a wide range of cellular functions, including development, gene expression, cytoskeletal organization, protein translation, cell cycle regulation, and apoptosis. [12] [13] [14] In contrast to many protein kinases, GSK3b is catalytically active even in unstimulated cells and becomes inactivated by phosphorylation at serine 9. Conversely, dephosphorylation of this site or mutations that prevent phosphorylation, result in activation of the kinase. Several protein kinases including protein kinase B (PKB, also knows as Akt), protein kinase A and C, integrin-linked kinase, and p90 Rsk kinase, have been identified to negatively regulate GSK3b activity through serine phosphorylation. GSK3b is also inhibited by Wingless/Wnt signaling. However, phosphorylation of GSK3b at tyrosine 216 by tyrosine kinases can further increase its activity.
A number of GSK3b substrates has been identified, such as b-catenin, CREB, NFAT, cyclin D1, c-Myc, E-cadherin, and eIF2B. [12] [13] [14] Among them, b-catenin is one of the best characterized targets of GSK3b. GSK3b phosphorylates b-catenin, targeting it for ubiquitination and degradation by proteasome. 13 At the cell membrane, b-catenin links cadherins to the cytoskeleton, modulating cytoskeleton organization. b-catenin also functions as a transcriptional activator. Accumulation of b-catenin in the cytosol leads to its translocation to the nucleus, where it binds with T-cell factor (TCF)/lymphocyte enhancer factor (LEF) family members to induce expression of several survival genes. 13 In this study, we explored the role of GSK3b in the regulation of CVB3-induced CPE and apoptosis in cultured cells. We demonstrate that CVB3 infection stimulates tyrosine kinase-dependent GSK3b activity, and inhibition of GSK3b activity prevents CVB3-induced CPE and apoptosis via stabilization of b-catenin.
Results

CVB3 stimulates GSK3b activation
To determine whether CVB3 infection can activate GSK3b, we examined GSK3b kinase activity by an immune complex kinase assay at different time courses following CVB3 infection. There was a significant increase in GSK3b activity at 1 h postinfection (pi) and subsequent decrease at 4 h pi ( Figure 1 ).
Tyrosine kinase inhibitors block CVB3-induced GSK3b activation
Previous studies have shown that Src family tyrosine kinases are activated early after CVB3 infection. 15, 16 To determine whether CVB3 infection activates tyrosine kinases, we examined tyrosine phosphorylation by Western blot analysis using antiphosphotyrosine monoclonal antibody. Consistent with previous reports, we demonstrated that CVB3 infection led to tyrosine phosphorylation as early as 10 min and peaked at 30 min following virus infection (Figure 2a ). CVB3-induced tyrosine phosphorylation was dramatically reduced after addition of PP2 (a selective Src tyrosine kinase inhibitor). We further explored whether tyrosine kinases function as upstream activators triggering GSK3b activation following CVB3 infection by using two tyrosine kinase inhibitors PP2 and genistein (a general tyrosine kinase inhibitor). As shown in Figure 2b , treatment with PP2 or genistein significantly reduced CVB3-induced GSK3b activation at 1 h pi, suggesting that CVB3 regulates GSK3b activity through the activation of tyrosine kinases.
GSK3b inhibitors block CVB3-induced CPE and apoptosis
GSK3b has been implicated in the regulation of apoptosis in a variety of cell types. [12] [13] [14] Overexpression of catalytically active GSK3b induced apoptosis in neuron cells and fibroblasts 17 and contributes to human immunodeficiency virus type 1 Tat-mediated neurotoxicity. 18 To examine whether inhibition of GSK3b activity protects cells against CVB3-induced CPE and apoptosis, we used two selective GSK3b inhibitors, LiCl and SB 415286. Inhibitor LiCl potently Figure 1 CVB3 infection stimulates GSK3b activation. Growth arrested HeLa cells were infected with CVB3. At 10 min, 1 h, 4 h and 7 h postinfection (pi), cell lysates were collected. GSK3b activity was determined by in vitro immune complex kinase assay (mean7S.E., n ¼ 4), and normalized to sham-infected cells, which was arbitrarily set to a value of 1.0. To verify equal amounts of precipitated GSK3b, 10 ml reaction mixture was separated on an SDS-PAGE gel and Western blot was performed using anti-GSK3b antibody Figure 3a , both LiCl and SB 415286 prevented CVB3-induced cell death in a dose-dependent manner.
Caspase activation is an important event in CVB3-induced apoptosis, which leads to cleavage of downstream substrates and DNA fragmentation. 10 Thus, we next examined the effect of GSK3b inhibition on CVB3-induced caspase-3 cleavage. We demonstrated that pretreatment with LiCl or SB 415286 dose-dependently inhibited CVB3-induced caspase-3 cleavage ( Figure 3b ). We further found that the inhibitory effect was almost abolished when LiCl or SB 415286 was added 3 h after infection, when GSK3b levels returned to almost baseline (data not shown), supporting the notion that the inhibition of apoptosis by GSK3b inhibitors is dependent on the blockade of GSK3b activity.
We have previously demonstrated CPE and apoptosis following CVB3 infection of HeLa cells are two separate cellular responses to virus infection. Caspase activation and subsequent substrate cleavage are not responsible for coxsackievirus-induced cytopathic morphological changes, which include cell shrinking, rounding and eventually floating. 10, 11 Here, we further test whether inhibition of GSK3b activity prevents infected cells from morphological changes. As shown in Figure 3c , vehicle (DMSO)-treated cells exhibited 
Inhibition of GSK3b decreases viral progeny release but not viral protein expression
To further explore whether the inhibitory effect of GSK3b inhibitors on CPE and apoptosis is directly regulated by the GSK3b pathway or whether it is secondary to inhibition of virus replication, we examined the impact of GSK3b inhibition on viral protein production. HeLa cells were incubated with varying concentrations of LiCl and SB 415286 for 30 min, followed by CVB3 infection. At 9 h pi, cell lysates were harvested for viral protein detection by Western blot. As shown in Figure 4a , the expression of viral capsid protein VP1 was unaltered in either the presence or absence of GSK3b inhibitors, indicating that GSK3b appears to directly regulate CVB3-induced apoptosis and CPE.
Apoptosis or cell death has been suggested to be beneficial for coxsackievirus infection via facilitating viral progeny release and spread. 10, 11 We examined the role of GSK3b inhibitors in viral progeny release. As expected, addition of LiCl or SB 415286 led to reduced virus titers in the supernatant as assessed by plaque assay (Figure 4b ), supporting an important role for apoptosis in virus lifecycle.
CVB3 reduces b-catenin expression via a GSK3b-dependent mechanism
To further elucidate the mechanisms by which GSK3b regulates CVB3-induced CPE and apoptosis, we examined the downstream targets of GSK3b. b-Catenin is one of the major targets of GSK3b and has been implicated to play a critical role in cell survival and cytoskeleton organization.
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GSK3b targets b-catenin for ubiquitination and degradation through the proteasome pathway. We first examined the expression of b-catenin following CVB3 infection. We found that CVB3 infection led to decreased expression of b-catenin at 5 and 7 h pi (Figure 5a ). To further clarify whether CVB3 infection affects membrane and/or cytoplasmic levels of b-catenin, cell fractionation was carried out. We found that both membrane and cytoplasmic levels of b-catenin were reduced after viral infection (Figure 5b ). We then determined whether CVB3-mediated downregulation of b-catenin is dependent on GSK3b activity. We examined the b-catenin expression in the SB 415286-treated cells following 5 h virus infection. As shown in Figure 6a , CVB3-induced decreased expression of b-catenin was reversed after addition of SB 415286, which is consistent with our previous finding that LiCl induced an accumulation of b-catenin in infected HeLa cells, 22 indicating that CVB3-mediated downregulation of b-catenin is dependent on GSK3b activation. To further clarify how GSK3b inhibitors affect b-catenin expression and subsequently prevent virus-induced CPE and apoptosis, we performed immunocytochemical staining to detect the expression and localization of b-catenin. Immunofluorescent microscopy revealed that in unstimulated cells, b-catenin was localized to the plasma membrane and the cytosol (Figure 6b) . Following CVB3 infection, cells appeared rounded up and b-catenin expression was decreased. Upon addition of LiCl and SB 415286, however, CVB3-induced CPE was prevented, accompanied by an increased membrane localization and nuclear translocation of b-catenin. In comparison, inhibition of caspase activation using the general caspase inhibitor zVAD.fmk had no effect on either CVB3-induced cell morphological changes or b-catenin expression and localization (Figure 6b ), indicating that GSK3 b-related morphological changes are independent of caspase activity. 
Overexpression of b-catenin inhibits CVB3-induced CPE and apoptosis
To further investigate the contribution of b-catenin as a key downstream effector of GSK3b to CVB3-induced CPE and apoptosis, we established stable cell lines overexpressing wild-type b-catenin or vector control (Figure 7a ). Cell lines containing the plasmid pCIneo-b-catenin or vector alone were infected with CVB3. At 9 or 16 h pi, influence of b-catenin overexpression on CPE and apoptosis was determined morphologically, by cell viability assay and Western blot. As compared to vector alone control, overexpression of b-catenin resulted in a significant reduction of CVB3-mediated cell death as measured by cell viability assay (Figure 7b) . Furthermore, immunoblotting for caspase-3 cleavage was performed to evaluate CVB3-induced apoptosis. We found that CVB3-induced caspase-3 cleavage was inhibited in cells overexpressing b-catenin (Figure 7c ). As well, b-catenin overexpression alleviated degenerative morphology in CVB3-infected cells (Figure 7d ). Taken together, the data obtained by overexpressing b-catenin in CVB3-infected cells are consistent with those obtained by inhibition of GSK3b, indicating that b-catenin is a major downstream of GSK3b contributing to the regulation of CVB3-induced CPE and apoptosis.
Overexpression of b-catenin inhibits viral progeny release but not viral protein expression
We have demonstrated that inhibition of GSK3b decreases viral progeny release. To further elucidate whether the contribution of GSK3b to viral progeny release is via b-catenin, viral protein VP1 and virus titer were measured by Western blot and plaque assay at 9 h pi, respectively. Similar to the results obtained by inhibiting GSK3b activity using LiCl or SB 415286 (Figure 4) , overexpression of bcatenin inhibited viral progeny release but not viral protein synthesis (Figure 8a, b) , suggesting that regulatory effect of GSK3b on virus release may be through the regulation of its downstream target b-catenin.
Discussion
In the present study, we have shown that CVB3 infection stimulates GSK3b activity via an upstream signaling pathway depending on the activation of tyrosine kinases. Inhibition of GSK3b activity prevents CVB3-induced CPE and apoptosis. We have further shown that CVB3 infection reduces the expression of b-catenin through a GSK3b-dependent mechanism. b-Catenin overexpression alleviates CVB3-induced At 7 h pi, cell lysates were harvested and then fractionated into the cytoplasmic and membrane fractions as described in 'Material and Methods'. b-Catenin expression was quantitated by densitometric analysis, and normalized to the sham-infected cells, which was arbitrarily set to a value of 1.0 CPE and apoptosis, similar to the effects obtained by GSK3b inhibitor treatment. Additionally, inhibition of GSK3b activity or overexpression of b-catenin reduces viral progeny release, but has no effect on viral protein synthesis. Thus, our data demonstrate, for the first time, that GSK3b pathway plays a critical role in the regulation of CVB3-induced CPE and apoptosis. Together with previous report that GSK3b activation induced by HIV-1 Tat protein is responsible for virusmediated neurotoxicity, 18 our finding in this study raises the possibility that GSK3b activation may represent a general strategy evolved by various cytopathic viruses to induce CPE and cell apoptosis although further experiment is necessary to test this hypothesis.
The activity of GSK3b is regulated by phosphorylation at both serine and tyrosine residues. Phosphorylation of GSK3b at Ser9 inhibits its enzymatic activity, whereas phosphorylation at Tyr216 can further increase its kinase activity. 23, 24 Tyrosine kinases such as proline-rich tyrosine kinase, 25 Src family member Fyn tyrosine kinase, 26 and zaphod tyrosine kinase 27 have been reported to activate GSK3b through tyrosine phosphorylation. In this study, we have shown that CVB3 infection stimulates GSK3b activity at 1 h pi via a tyrosine kinase-dependent mechanism. Although the exact tyrosine kinase(s) has not yet been identified, the Src tyrosine kinase family members, which were shown to be activated early after virus infection, 15, 16 are likely the upstream kinases responsible to GSK3b activation during CVB3 infection. At 4 h pi, GSK3b activity returns to basal levels. It is not clear whether such reduction is due to transient virus-receptor binding effect or due to negative regulation by upstream kinases. We have recently reported that CVB3 induces phosphatidylinositol 3 kinase (PI3K)/PKB activation after 3 h of infection. 28, 29 Serine phosphorylation of GSK3b by PKB leads to a decreased GSK3b activity. Therefore, it is likely that downregulation of GSK3b activity at 4 h pi is caused by increased PKB phosphorylation. Indeed, we have shown that GSK3b serine phosphorylation occurs following CVB3 infection. 28 Taken together, during the course of CVB3 infection, the 1 h peak of GSK3b activity and the 4 h return to baseline are likely to be rendered by different signaling pathways, reflecting the multiple virus and host mechanisms involved in virus infection and the crosstalk that exists between various pathways.
Studies by our laboratory and others have suggested that CPE and apoptosis triggered by CVB3 infection are two separate cellular responses. CPE is a typical feature of CVB3 infection, characterized by degenerative changes in cell morphology, which includes cell shrinkage, cell rounding, and eventually cell detachment. Apoptosis is a distinct type of cell death following CVB3 infection, which is characterized by internucleosomal fragmentation of the genomic DNA. Cysteine protease caspases are the main executor enzymes of apoptotic process. In both CVB3 and poliovirus studies, it has been demonstrated that caspases are activated subsequent to degenerative morphological changes and that caspase inhibitors are able to inhibit apoptosis but not CPE, indicating that the pathways leading to the virus-induced CPE and apoptosis are separate. 10, 30 It has been suggested that viral proteases induce cleavage of host proteins, which may be responsible for changes in cell shape. 31 However, the mechanisms of CPE remain largely unknown. In this study, we have demonstrated that the GSK3b/b-catenin pathway acts as a multifunctional regulator of both CVB3-induced CPE and apoptosis.
Coxsackievirus B3 utilizes host cellular machinery in many different ways to promote infectivity. Our laboratory has reported that several signaling pathways participate in the regulation of CVB3 replication. For example, CVB3 activates the extracellular signal-regulated kinase and PI3K/PKB signaling pathways during the course of infection to facilitate its own replication. 28, 32 If PI3K regulates viral replication through GSK3b, inhibition of PI3K or overactivation of GSK3b should exert consistent effects on viral protein expression and progeny release since PI3K is a negative regulator to GSK3b. However, we have shown that inhibition of GSK3b does not affect viral protein expression, but reduces virus release. This discrepancy could be due to the involvement of other downstream effector(s) of PI3K/PKB in the regulation of CVB3 replication. We have previously shown that overexpression of Bcl-2 or Bcl-xL, or treatment with caspase inhibitor zVAD.fmk decreases virus release, suggesting that host cell apoptosis facilitates the release of progeny virus from infected cells.
11 Thus, the mechanism by which LiCl or SB 415286 inhibits virus release is likely an indirect result of their antiapoptotic effects in infected cells.
Many proteins have been reported to be substrates of GSK3b. 33 Based on its known functions, b-catenin, a substrate of GSK3b, is likely a candidate participating in the regulation of apoptosis and CPE during CVB3 infection. Two major functions of b-catenin have been well described: the membrane-tethered b-catenin links adherens junction protein cadherins to the actin cytoskeleton, promoting cell-cell adhesion; and the cytoplasmic b-catenin functions as a transcriptional activator participating in maintaining cell survival. 34 Recent studies have suggested that cells adapt various mechanisms to regulate the levels and localization of b-catenin to assure its specific function at different Cell lysates were collected 9 h postinfection and Western blot analysis was performed using a polyclonal antibody that recognizes capsid protein VP1. These same samples were immunoblotted with an antibody to b-actin to illustrate equal protein loading. (b) Stable cell lines were infected with CVB3 as described above. Medium was collected from CVB3 infected cells 9 h following infection and virus titers were determined by plaque assays. Values are mean7S.E. from three independent experiments, where titrations were carried out in triplicate conditions. 34 During the cell cycle, protein expression of cytosolic b-catenin fluctuates, increasing at S phase, reaching maximum at late G2/M phase, then rapidly reducing in the next G1 phase. 35, 36 Knockdown of b-catenin gene expression using RNA interference results in cell growth arrest and detachment, whereas stabilization of b-catenin suppresses cell apoptosis. [37] [38] [39] [40] [41] [42] [43] In this study, we have shown that CVB3 infection decreases protein expression of b-catenin via a GSK3b-dependent mechanism, and overexpression of b-catenin inhibits CVB3-induced apoptosis and CPE. These findings suggest b-catenin is a key downstream effector of GSK3b in the regulation of apoptosis and cell morphology. Although the precise mechanisms by which b-catenin regulates CVB3-induced apoptosis are still unclear, we speculate that over the course of CVB3 infection, the balance of b-catenin protein levels and subcellular localization is altered, which results in an early CPE (via loss of membrane b-catenin) and a late apoptosis (via inhibition of antiapoptotic b-catenin signaling through the nucleus) of infected cells. However, we cannot rule out the possibility that other downstream targets of GSK3b, such as c-Myc, c-Jun, CREB, STAT, and NFAT, may also play a role in GSK3b activationinduced CPE and apoptosis during CVB3 infection.
Based on our findings in this study, a proposed model is summarized in Figure 9 . CVB3 infection increases GSK3b activity through an upstream pathway depending on the activation of tyrosine kinases. Inhibition of GSK3b activity by LiCl or SB 415286 leads to stabilization and accumulation of b-catenin in the cytoplasm, which in turn results in an increased membrane localization and nuclear translocation of b-catenin. Membrane-associated b-catenin links cadherin to cytoskeleton organization, resisting morphological destruction by CVB3. Nuclear-localized b-catenin binds with TCF/ LEF family members to trigger the expression of genes responsible for maintaining cell survival.
In summary, our findings elucidate the essential role of GSK3b signaling in host cells response to CVB3 infection.
Considering the importance of CPE and apoptosis in viral infection, in host tissue damage, and in the progression to chronic diseases, modulating GSK3b activity or b-catenin expression may have important therapeutic implications.
Materials and Methods
Cell culture and virus propagation
HeLa cells were obtained from Charles Gauntt (University of Nebraska Medical Center, Nebraska, Omaha). They were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% newborn calf serum and 100 mg/ml penicillin/streptomycin (Invitrogen Life Technologies) at 371C in a humidified incubator with 5% CO 2 . CVB3 (Nancy strain) was propagated in HeLa cells and stored at À801C. Virus titers were routinely determined at the beginning of the experiment by plaque assay.
Virus infection
To minimize the influence of serum on the activation of signaling proteins, prior to virus infection, HeLa cells were serum starved by incubation in serum-free medium for 24 h. Immune complex kinase assay GSK3b activity was determined by an immune complex kinase assay using glycogen synthase peptide-2 (Upstate Biotechnology) as a substrate as previously described. 44 Briefly, 500 mg of protein extracts from each sample were incubated with 1 mg anti-GSK3b antibody (BD Biosciences Pharmingen) for 2 h and then immunoprecipitated with precleared protein G-Sepharose (Roche Applied Science) for 1 h. Beads were washed and kinase activity was assayed in a total volume of 50 ml reaction buffer containing 62.5 mM glycogen synthase peptide-2, 20 mM MOPS, 25 mM b-glycerol phosphate (pH 7.2), 1 mM EGTA, 1 mM sodium orthovanadate, 1 mM dithiothreitol, 15 mM MgCl 2 , 20 mM ATP and 1 mCi g[ 32 P]ATP. After 20 min of incubation at 301C, reaction mixtures were centrifuged and 30 ml of the supernatant was spotted onto P81 phosphocellulose papers (Whatman). Filters were washed in four changes of 0.75% phosphoric acid, rinsed in acetone, dried and then subjected to liquid scintillation counting. To verify equal amounts of precipitated GSK3b, 10 ml reaction mixture was separated on a sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blot was performed using antiGSK3b antibody.
Cell viability assay
Cell viability (cell mitochondrial function) was measured by a 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium salt (MTS) assay (Promega), according to the manufacturers' instructions. Briefly, cells were incubated with MTS solution for 2 h and absorbance was measured at 492 nm using an enzyme-linked 45 We demonstrated that overexpression of b-catenin was sufficient to activate TCF/LEF transcription in HeLa cells (data not shown).
Western blot analysis
Western blot was performed by standard protocols as previously described. 46 Equal amounts of protein were subjected to SDS-PAGE and then transferred onto nitrocellulose membranes. The membranes were blocked with 5% skim milk solution containing 0.1% Tween-20 for 1 h. The blots were then probed with primary antibody (monoclonal anti-bcatenin antibody (BD Transduction Laboratories); monoclonal antiphosphotyrosine antibody (PY20, Transduction Laboratories); monoclonal anti-b-actin antibody (Sigma); monoclonal antibody against viral protein VP1 (DAKO Co.); and polyclonal anti-caspase-3 antibody (Santa Cruz Biotechnology)) for 1 h, followed by incubation with horseradish peroxidase-conjugated secondary antibody (Santa Cruz Biotechnology). Protein expression was detected by enhanced chemiluminescence (Amersham).
Cell fractionation
Cell fractionation was performed as previously described. 47 Briefly, HeLa cells were washed with PBS, and then incubated in hypotonic lysis buffer (20 mM HEPES, pH 7.8, 10 mM KCl with phosphatase and protease inhibitors) for 15 min on ice. Cell lysates were harvested and then homogenized with 20 stokes in a Dounce homogenizer. After centrifugation at 250 Â g for 5 min to remove the nuclei and intact cells, the supernatant was collected and then further centrifuged at 100 000 Â g for 1 h to separate the cytoplasm from the membrane fraction. Western blotting with an anti-DAF antibody was confirmed that there was no contamination of the cytoplasmic fractions with membrane fractions.
Viral plaque assay
The viral titer in the supernatant was determined by plaque assay as described previously. 48 Cell supernatant was serially diluted and overlaid on monolayer of HeLa cells. Following 1 h of incubation, medium was removed and complete DMEM containing 0.75% agar was overlaid. After 3 days, cells were fixed with Carnoy's fixative for 30 min and then stained with 1% crystal violet. The plaques were counted and the viral titer (plaque-forming unit (PFU)/ml) was calculated.
Immunocytochemical staining
For visualization of b-catenin, cells were immunocytochemically stained using a monoclonal anti-b-catenin antibody. Briefly, following fixation in 10% formalin and permeabilization in 0.1% Triton X-100, cells were blocked with 10% normal goat serum for 1 h, and then incubated with primary mouse anti-b-catenin antibody overnight. AlexaFluor s 594-labeled goat anti-mouse IgG (Molecular Probes) was used to visualize primary antibody and Hoechst 33342 (Molecular Probes) was used to stain nuclei. Cells were imaged using a Nikon inverted microscope and Spot digital camera.
Statistical analysis
Two-way analysis of variance with multiple comparisons and paired Student's t-tests were performed. Data were shown as the mean7 standard error (S.E.). Po0.05 was considered significant.
